blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2328594

EP2328594 - STROMAL STEM CELLS DERIVED FORM ADIPOSE TISSUE FOR USE IN TREATING SIRS [Right-click to bookmark this link]
Former [2011/23]USES OF MESENCHYMAL STEM CELLS
[2015/36]
StatusNo opposition filed within time limit
Status updated on  20.01.2017
Database last updated on 03.10.2024
Most recent event   Tooltip20.07.2018Lapse of the patent in a contracting state
New state(s): MT		published on 22.08.2018  [2018/34]
Applicant(s)For all designated states
TiGenix, S.A.U.
Parque Tecnologico de Madrid C/ Marconi, 1
28760 Tres Cantos - Madrid / ES
For all designated states
Consejo Superior De Investigaciones Científicas
C/ Serrano 117
28006 Madrid / ES
For all designated states
Universidad de Sevilla
Pabellón de Brasil Paseo de las Delicias s/n
41013 Sevilla / ES
[N/P]
Former [2016/04]For all designated states
TiGenix, S.A.U.
Parque Tecnologico de Madrid C/ Marconi, 1
28760 Tres Cantos - Madrid / ES
For all designated states
Consejo Superior De Investigaciones Científicas
Serrano 117
28006 Madrid / ES
For all designated states
Universidad de Sevilla
Pabellón de Brasil Paseo de las Delicias s/n
41013 Sevilla / ES
Former [2011/23]For all designated states
Cellerix SA
Calle Marconi 1 Parque Technologico de Madrid
28760 Tres Cantos, Madrid / ES
For all designated states
Consejo Superior De Investigaciones Científicas
C/ Serrano 117
28006 Madrid / ES
Inventor(s)01 / DELGADO, Mario
Instituto De Parasitología Y Biomedicina
"López-Neyra"
CSIC Avda. Conocimiento S/N
Parque Tecnologico, Ciencias de la Salud
18100 Armilla (Granada) / ES
02 / GONZALEZ-REY, Elena
School of Medicine
University of Seville
Seville / ES
03 / BÜSCHER, Dirk
Parque Tecnológico de Madrid
Calle Marconi 1
28760 Tres Cantos Madrid / ES
 [2016/11]
Former [2011/23]01 / DELGADO, Mario
Instituto De Parasitología Y Biomedicina "López-Neyra" CSIC Avda. Conocimiento S/N Parque Tecnologico Ciencias de la Salud
18100 Armilla (Granada) / ES
02 / GONZALEZ-REY, Elena
School of Medicine University of Seville
Seville / ES
03 / BÜSCHER, Dirk
Parque Tecnológico de Madrid Calle Marconi 1
28760 Tres Cantos Madrid / ES
Representative(s)Goodfellow, Hugh Robin
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2016/11]
Former [2011/23]Goodfellow, Hugh Robin
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Application number, filing date09786159.503.08.2009
[2011/23]
WO2009IB06597
Priority number, dateGB2008001424904.08.2008         Original published format: GB 0814249
[2011/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010015929
Date:11.02.2010
Language:EN
[2010/06]
Type: A2 Application without search report 
No.:EP2328594
Date:08.06.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 11.02.2010 takes the place of the publication of the European patent application.
[2011/23]
Type: B1 Patent specification 
No.:EP2328594
Date:16.03.2016
Language:EN
[2016/11]
Search report(s)International search report - published on:EP29.04.2010
ClassificationIPC:A61K35/28, A61P29/00
[2011/23]
CPC:
A61K35/28 (EP,KR,US); A61K45/06 (KR); A61K9/0019 (KR);
A61P29/00 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P31/12 (EP); A61P33/00 (EP); A61P33/02 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P7/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/11]
Former [2011/23]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:STROMALE STAMMZELLEN GEWONNEN AUS FETTGEWEBE ZUR VERWENDUNG IN DER BEHANDLUNG VON SIRS[2015/40]
English:STROMAL STEM CELLS DERIVED FORM ADIPOSE TISSUE FOR USE IN TREATING SIRS[2015/40]
French:CSM DÉRIVÉE DU TISSU ADIPEUX POUR UTILISATION DANS LE TRAITEMENT SRIS[2015/40]
Former [2011/23]VERWENDUNGSZWECKE VON MESENCHYMSTAMMZELLEN
Former [2011/23]USES OF MESENCHYMAL STEM CELLS
Former [2011/23]UTILISATIONS DE CELLULES SOUCHES MÉSENCHYMATEUSES
Entry into regional phase02.03.2011National basic fee paid 
02.03.2011Designation fee(s) paid 
02.03.2011Examination fee paid 
Examination procedure02.03.2011Amendment by applicant (claims and/or description)
02.03.2011Examination requested  [2011/23]
07.03.2013Despatch of a communication from the examining division (Time limit: M06)
15.10.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
20.12.2013Reply to a communication from the examining division
31.08.2015Communication of intention to grant the patent
11.01.2016Fee for grant paid
11.01.2016Fee for publishing/printing paid
11.01.2016Receipt of the translation of the claim(s)
Divisional application(s)EP16160083.8  / EP3095449
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.03.2013
Opposition(s)19.12.2016No opposition filed within time limit [2017/08]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.12.2013Request for further processing filed
20.12.2013Full payment received (date of receipt of payment)
Request granted
17.01.2014Decision despatched
Fees paidRenewal fee
11.08.2011Renewal fee patent year 03
10.08.2012Renewal fee patent year 04
19.08.2013Renewal fee patent year 05
31.07.2014Renewal fee patent year 06
06.08.2015Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY16.03.2016
EE16.03.2016
HR16.03.2016
LT16.03.2016
LV16.03.2016
MC16.03.2016
MK16.03.2016
RO16.03.2016
SI16.03.2016
SK16.03.2016
SM16.03.2016
TR16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
MT31.08.2016
[2018/33]
Former [2018/29]CY16.03.2016
EE16.03.2016
HR16.03.2016
LT16.03.2016
LV16.03.2016
MC16.03.2016
MK16.03.2016
RO16.03.2016
SI16.03.2016
SK16.03.2016
SM16.03.2016
TR16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
Former [2017/23]EE16.03.2016
HR16.03.2016
LT16.03.2016
LV16.03.2016
MC16.03.2016
RO16.03.2016
SI16.03.2016
SK16.03.2016
SM16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
Former [2017/20]EE16.03.2016
HR16.03.2016
LT16.03.2016
LV16.03.2016
MC16.03.2016
RO16.03.2016
SK16.03.2016
SM16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
Former [2016/50]EE16.03.2016
HR16.03.2016
LT16.03.2016
LV16.03.2016
RO16.03.2016
SK16.03.2016
SM16.03.2016
GR17.06.2016
IS16.07.2016
Former [2016/49]EE16.03.2016
HR16.03.2016
LT16.03.2016
LV16.03.2016
GR17.06.2016
IS16.07.2016
Former [2016/48]HR16.03.2016
LT16.03.2016
LV16.03.2016
GR17.06.2016
IS16.07.2016
Former [2016/39]HR16.03.2016
LT16.03.2016
LV16.03.2016
GR17.06.2016
Former [2016/36]HR16.03.2016
LT16.03.2016
GR17.06.2016
Former [2016/35]HR16.03.2016
GR17.06.2016
Cited inInternational search[XYI]WO2005093044  (OSIRIS THERAPEUTICS INC [US], et al) [X] 1-4,9,11,13-22,24-25,29-30 * page 2, column 2 * * page 3, column 1 * * page 4, columns 4,5 * * page 5, columns 1,4 * * page 6, column 5 - page 7, columns 1,5 * * page 9, column 3 * * page 10, columns 3,5 * * page 11, column 3 * * page 15, column 3 * [Y] 1-30 [I] 5-6,10,12,23,26-28;
 [Y]  - LE BLANC K ET AL, "Immunomodulation by mesenchymal stem cells and clinical experience.", JOURNAL OF INTERNAL MEDICINE NOV 2007, (200711), vol. 262, no. 5, ISSN 0954-6820, pages 509 - 525, XP002571510 [Y] 1-30 * page 509, column 4 * * page 510, column 3 * * page 511, columns 1,2 * * page 512, column 2 * * page 513, column 2 * * page 514, columns 6,7 * * page 515, columns 2,3 * * page 516, column 4 * * page 517, columns 2,3 * * page 519, columns 1,3-5 * * page 520, columns 2,4 *

DOI:   http://dx.doi.org/10.1111/J.1365-2796.2007.01844.X
 [A]  - WAGNER ET AL, "Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, (20051101), vol. 33, no. 11, ISSN 0301-472X, pages 1402 - 1416, XP005136979 [A] 1-30 * page 1402, column 1 * * page 1403, columns 2,4 * * page 1405, column 5 * * page 1414, column 3 *

DOI:   http://dx.doi.org/10.1016/j.exphem.2005.07.003
 [Y]  - KIM JEONG-MIN ET AL, "Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model.", BRAIN RESEARCH 5 DEC 2007, (20071205), vol. 1183, ISSN 0006-8993, pages 43 - 50, XP002571511 [Y] 1-30 * page 44, columns 2,3,5 * * page 46, columns 5,6 * * page 47, columns 1-3 *

DOI:   http://dx.doi.org/10.1016/J.BRAINRES.2007.09.005
 [Y]  - XU JIANGUO ET AL, "Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice.", AMERICAN JOURNAL OF PHYSIOLOGY. LUNG CELLULAR AND MOLECULAR PHYSIOLOGY JUL 2007, (200707), vol. 293, no. 1, ISSN 1040-0605, pages L131 - L141, XP002571512 [Y] 1-30 * page 131, columns 2,3 * * page 133, column 9 * * page 134, column 1 * * page 136, columns 4,5 * * page 140, columns 3-5 * * page 141, column 1 *

DOI:   http://dx.doi.org/10.1152/ajplung.00431.2006
 [A]  - KAN I ET AL, "Integral therapeutic potential of bone marrow mesenchymal stem cells", CURRENT DRUG TARGETS, BENTHAM SCIENCE PUBLISHER, US, (20050201), vol. 6, no. 1, ISSN 1389-4501, pages 31 - 41, XP002456405 [A] 1-30 * page 33, column 5 * * page 38, columns 5-8 * * page 39, column 2 *

DOI:   http://dx.doi.org/10.2174/1389450053344902
by applicantWO2005093044
    - NYSTROM, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (1998), vol. 41, no. A, pages 1 - 7
 US20050065461
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.